702 related articles for article (PubMed ID: 15717649)
1. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
2. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
Chapman IM; Wittert GA; Norman RJ
Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
[TBL] [Abstract][Full Text] [Related]
4. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
5. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
8. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.
Mannerås-Holm L; Leonhardt H; Kullberg J; Jennische E; Odén A; Holm G; Hellström M; Lönn L; Olivecrona G; Stener-Victorin E; Lönn M
J Clin Endocrinol Metab; 2011 Feb; 96(2):E304-11. PubMed ID: 21084397
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
15. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
[TBL] [Abstract][Full Text] [Related]
16. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.
O'Connor A; Phelan N; Tun TK; Boran G; Gibney J; Roche HM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1378-85. PubMed ID: 20080859
[TBL] [Abstract][Full Text] [Related]
17. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
Wehr E; Gruber HJ; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2011 Jun; 96(6):E986-90. PubMed ID: 21470992
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
20. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]